Skip to main content
. 2021 Jan 8;15:93–103. doi: 10.2147/OPTH.S284872

Table 3.

Repeatability of Macular Vascular Density Measurement Obtained Using OCTA for Eyes with and without CME or Retinal Vasculopathy. (A) 3x3 mm OCTA Scans. (B) 6x6 mm OCTA Scans

A. Repeatability of Macular Vascular Density Measurement for 3x3 mm OCTA Scans
3x3 mm Scan CME (n=16) No CME (n=38) Vasculopathy without CME (n=15)
CV, Mean (SD)% ICC
(95% CI)
CV, Mean (SD)% ICC
(95% CI)
CV, Mean (SD)% ICC
(95% CI)
SCP
ETDRS 4.5 (3.3) 0.883
(0.687–0.959)
3.3
(2.4)
0.902
(0.820–0.948)
3.4
(2.6)
0.909
(0.752–0.969)
Fovea 11.5 (7.2) 0.885
(0.702–0.958)
9.4
(9.5)
0.908
(0.831–0.951)
10.2
(9.6)
0.914
(0.764–0.970)
3 mm inner ring 4.1 (2.8) 0.903
(0.737–0.966)
3.3
(2.5)
0.899
(0.815–0.946)
3.4
(2.6)
0.912
(0.758–0.969)
DCP
ETDRS 4.0 (4.1) 0.188
(−0.323–0.615)
3.0
(2.6)
0.806
(0.657–0.894)
3.2
(2.7)
0.858
(0.630–0.950)
Fovea 9.9 (15.7) 0.747
(0.414–0.904)
4.8
(2.9)
0.953
(0.912–0.976)
6.2
(3.4)
0.940
(0.832–0.980)
3 mm inner ring 4.5 (4.6) 0.804
(0.511–0.930)
3.1
(2.9)
0.783
(0.620–0.881)
3.2
(3.1)
0.843
(0.595–0.944)
cDCP
ETDRS 13.4 (35.6) 0.342
(−0.187–0.717)
8.2
(7.4)
0.877
(0.776–0.934)
6.8
(5.1)
0.933
(0.814–0.977)
Fovea 10.7 (7.2) 0.840
(0.600–0.941)
13.5
(11.7)
0.613
(0.369–0.779)
14.5 (12.7) 0.581
(0.118–0.837)
3 mm inner ring 4.3 (3.9) 0.836
(0.580–0.942)
7.6
(7.2)
0.666
(0.443–0.811)
6.4
(4.9)
0.772
(0.446–0.917)
cICP
ETDRS 5.7
(3.2)
0.746
(0.316–0.920)
7.2
(7.1)
0.777
(0.525–0.895)
5.7
(5.9)
0.857
(0.488–0.969)
Fovea 3.6
(3.8)
0.944
(0.825–0.983)
9.6
(7.3)
0.800
(0.608–0.901)
9.8
(5.3)
0.883
(0.516–0.976)
3 mm inner ring 6.1
(3.5)
0.749
(0.322–0.921)
7.3
(7.1)
0.771
(0.537–0.889)
6.3
(6.4)
0.827
(0.399–0.962)
FAZ size 24.2 (48.2) 0.958
(0.885–0.985)
7.5
(20.4)
0.884
(0.787–0.938)
15.2 (31.2) 0.800
(0.502–0.928)
B. Repeatability of Macular Vascular Density Measurement for 6x6 mm OCTA Scans
6x6 mm Scan CME (n=12) No CME (n=35) Vasculopathy without CME (n=13)
CV, Mean (SD)% ICC
(95% CI)
CV, Mean (SD)% ICC
(95% CI)
CV, Mean (SD)% ICC
(95% CI)
SCP
ETDRS 4.4 (2.9) 0.837
(0.503–0.953)
2.8
(2.5)
0.936
(0.877–0.967)
2.8
(1.6)
0.947
(0.836–0.984)
Fovea 16.1 (8.0) 0.723
(0.282–0.911)
8.4
(8.2)
0.937
(0.878–0.968)
9.1
(5.2)
0.939
(0.812–0.981)
3 mm inner ring 4.5 (2.9) 0.859
(0.584–0.957)
3.4
(2.7)
0.923
(0.852–0.960)
4.3
(2.6)
0.914
(0.744–0.973)
6 mm outer ring 16.1 (39.6) 0.257
(−0.345–0.709)
3.1
(2.8)
0.925
(0.857–0.961)
3.3
(2.1)
0.917
(0.752–0.974)
DCP
ETDRS 3.5 (2.1) 0.928
(0.757–0.980)
3.6
(3.3)
0.844
(0.712–0.918)
4.9
(4.1)
0.822
(0.514–0.942
Fovea 15.6 (16.6) 0.399
(−0.198–0.780)
5.3
(4.5)
0.916
(0.841–0.957)
7.1
(5.7)
0.837
(0.551–0.947)
3 mm inner ring 3.6 (2.3) 0.902
(0.697–0.971)
2.3
(2.1)
0.900
(0.810–0.948)
2.9
(2.6)
0.898
(0.699–0.968)
6 mm outer ring 3.7 (2.3) 0.912
(0.709–0.976)
4.5
(4.1)
0.816
(0.665–0.902)
5.6
(3.5)
0.793
(0.452–0.932)
cDCP
ETDRS 7.3 (9.9) 0.574
(−0.430–0.874)
4.1
(3.4)
0.492
(0.183–0.712)
3.8
(3.5)
0.427
(−0.198–0.805)
Fovea 25.6 (22.3) 0.058
(−0.511–0.592)
10.4
(10.4)
0.736
(0.5537–0.857)
12.5 (11.4) 0.499
(−0.046–0.815)
3 mm inner ring 7.6 (12.9) 0.400
(−0.197–0.780)
4.2
(3.0)
0.624
(0.371–0.791
3.4
(2.3)
0.701
(0.269–0.898)
6 mm outer ring 18.3 (39.6) 0.216
(−0.383–0.687)
4.3
(3.6)
0.509
(0.216–0.718)
4.1
(4.1)
0.483
(−0.67–0.808)
cICP
ETDRS 5.9
(6.2)
0.774
(0.376–0.933)
5.5
(5.1)
0.338
(−0.002–0.611)
6.7
(7.0)
0.493
(−0.097–0.850)
Fovea 18.1
(22.2)
0.256
(−0.406–0.730)
7.7
(5.9)
0.735
(0.517–0.863)
12.4
(7.7)
0.147
(−0.231–0.640)
3 mm inner ring 9.6
(10.1)
0.451
(−0.074–0.806)
5.2
(4.6)
0.566
(0.276–0.763)
6.6
(5.3)
0.525
(−0.055–0.861)
6 mm outer ring 6.5
(6.1)
0.769
(0.332–0.937)
5.1
(5.2)
0.416
(0.095–0.663)
7.3
(8.0)
0.430
(−0.135–0.822)
FAZ size 19.1 (25.0) 0.895 (0.677–0.969) 6.5 (7.3) 0.957 (0.916–0.978) 7.8 (8.0) 0.935 (0.792–0.981)

Abbreviations: CV, coefficient of variation; ICC, intraclass coefficient; SCP, superficial capillary plexus; DCP, deep capillary plexus; cDCP, custom-segmented deep capillary plexus; FAZ, foveal avascular zone, cICP, custom-segmented intermediate capillary plexus; CME, cystoid macular edema; ETDRS, early treatment of diabetic retinopathy study macular region 6 mm diameter centered in the fovea.